Chromosomal instability and cancer: A complex relationship with therapeutic potential

Journal of Clinical Investigation

Volumn 122, Issue 4, 2012, Pages 1138-1143

  Bakhoum, Samuel F ^a   Compton, Duane A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; ARTICLE; CANCER PROGNOSIS; CHROMOSOMAL INSTABILITY; CHROMOSOME LOSS; CHROMOSOME NUMBER; CHROMOSOME SEGREGATION; DISEASE ASSOCIATION; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANEUPLOIDY; ANIMALS; ANTINEOPLASTIC AGENTS; CHROMOSOMAL INSTABILITY; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME SEGREGATION; HUMANS; MICE; MITOTIC SPINDLE APPARATUS; MOLECULAR TARGETED THERAPY; NEOPLASM PROTEINS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PROGNOSIS; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; SELECTION, GENETIC; SEQUENCE DELETION;

EID: 84859726409     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI59954     Document Type: Article

References (84)

1. Nowell PC. Clonal evolution of tumor-cell populations. Science. 1976;194(4260):23-28.
2. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature. 1997; 386(6625):623-627. (Pubitemid 27175430)
3. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998; 396(6712):643-649. (Pubitemid 29003936)
4. Cimini D. Merotelic kinetochore orientation, aneuploidy, and cancer. Biochim Biophys Acta. 2008; 1786(1):32-40.
5. Thompson SL, Compton DA. Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol. 2008;180(4):665-672. (Pubitemid 351397764)
6. Boveri T. Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J Cell Sci. 2008;121 suppl 1:1-84.
7. Receveur A, et al. Trisomy 4 associated with double minute chromosomes and MYC amplification in acute myeloblastic leukemia. Ann Genet. 2004; 47(4):423-427. (Pubitemid 39575623)
8. Goldstone A, et al. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial. Blood. 1998;92(7):2322-2333. (Pubitemid 28452973)
9. Grimwade D, et al. Hierarchical cytogenetic classification is highly predictive of outcome in AML arising at all ages: Analysis of 4225 cases entered in the UK MRC leukaemia trials. Blood. 2000;96:825a.
10. Gulley ML, Shea TC, Fedoriw Y. Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia. J Mol Diagn. 2010; 12(1):3-16.
11. Kobayashi K, Usami I, Kubota M, Nishio T, Kakazu N. Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome. Cancer Genet Cytogenet. 2005;158(2):184-187. (Pubitemid 40417702)
12. Sullivan SG, Hussain R, Glasson EJ, Bittles AH. The profile and incidence of cancer in Down syndrome. J Intellect Disabil Res. 2007;51(pt 3):228-231. (Pubitemid 46189568)
13. Patja K, Pukkala E, Sund R, Iivanainen M, Kaski M. Cancer incidence of persons with Down syndrome in Finland: A population-based study. Int J Cancer. 2006;118(7):1769-1772. (Pubitemid 43376441)
14. Hunter A. High risk of malignancy in mosaic variegated aneuploidy syndrome. Am J Med Genet A. 2003;117A(2):199. (Pubitemid 37064020)
15. Jacquemont S, Boceno M, Rival JM, Mechinaud F, David A. High risk of malignancy in mosaic variegated aneuploidy syndrome. Am J Med Genet. 2002;109(1):17-21. (Pubitemid 34259949)
16. Rahman N, et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet. 2004;36(11):1159-1161. (Pubitemid 41288963)
17. Paulsson K, Johansson B. Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes. Pathol Biol (Paris). 2007;55(1):37-48. (Pubitemid 46217945)
18. Compton DA. Spindle assembly in animal cells. Annu Rev Biochem. 2000;69:95-114.
19. Maiato H, DeLuca J, Salmon ED, Earnshaw WC. The dynamic kinetochore-microtubule interface. J Cell Sci. 2004;117(pt 23):5461-5477. (Pubitemid 40012194)
20. Thompson SL, Bakhoum SF, Compton DA. Mechanisms of chromosomal instability. Curr Biol. 2010;20(6):R285-R295.
21. Pati D, et al. Overexpression of Separase induces aneuploidy and mammary tumorigenesis. Proc Natl Acad Sci U S A. 2008;105(35):13033-13038.
22. Di Leonardo A, Lentini L, Amato A, Schillaci T. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype. BMC Cancer. 2007;7:212.
23. Silkworth WT, Nardi IK, Scholl LM, Cimini D. Multipolar spindle pole coalescence is a major source of kinetochore mis-attachment and chromosome mis-segregation in cancer cells. PloS One. 2009; 4(8):e6564.
24. Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature. 2009;460(7252):278-282.
25. Tusell L, Pampalona J, Soler D, Frias C, Genesca A. Different outcomes of telomere-dependent anaphase bridges. Biochem Soc Trans. 2010;38(6):1698-1703.
26. Cahill DP, et al. Mutations of mitotic check-point genes in human cancers. Nature. 1998; 392(6673):300-303. (Pubitemid 28155105)
27. Sotillo R, Schvartzman JM, Socci ND, Benezra R. Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature. 2010;464(7287):436-440.
28. Diaz-Rodriguez E, Sotillo R, Schvartzman JM, Benezra R. Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo. Proc Natl Acad Sci U S A. 2008;105(43):16719-16724.
29. Bakhoum SF, Thompson SL, Manning AL, Compton DA. Genome stability is ensured by temporal control of kinetochore-microtubule dynamics. Nat Cell Biol. 2009;11(1):27-35.
30. Bakhoum SF, Genovese G, Compton DA. Deviant kinetochore microtubule dynamics underlie chromosomal instability. Curr Biol. 2009; 19(22):1937-1942.
31. Cimini D, Howell BJ, Degrassi F, Salmon ED. Merotelic attachment of single kinetochores to microtubules from opposite poles is not detected by the mitotic spindle checkpoint and induces chromosome loss during mitosis. Mol Biol Cell. 2000; 11:430a.
32. Cimini D, Howell B, Maddox P, Khodjakov A, Degrassi F, Salmon ED. Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells. J Cell Biol. 2001; 153(3):517-527. (Pubitemid 34280139)
33. Khodjakov A, Magidson V, O'Connell CB, Loncarek J, Paul R, Mogilner A. The spatial arrangement of chromosomes during prometaphase facilitates spindle assembly. Cell. 2011;146(4):555-567.
34. Kapoor TM, et al. Chromosomes can congress to the metaphase plate before biorientation. Science. 2006;311(5759):388-391. (Pubitemid 43132665)
35. Loncarek J, et al. The centromere geometry essential for keeping mitosis error free is controlled by spindle forces. Nature. 2007;450(7170):745-749. (Pubitemid 350207690)
36. Cheeseman IM, Desai A. Molecular architecture of the kinetochore- microtubule interface. Nat Rev Mol Cell Biol. 2008;9(1):33-46.
37. Desai A, Mitchison TJ. Microtubule polymerization dynamics. Annu Rev Cell Dev Biol. 1997;13:83-117. (Pubitemid 28034521)
38. DeLuca JG, Gall WE, Ciferri C, Cimini D, Musacchio A, Salmon ED. Kinetochore microtubule dynamics and attachment stability are regulated by Hec1. Cell. 2006;127(5):969-982. (Pubitemid 44792254)
39. Bakhoum SF, Compton DA. Cancer: CINful centrosomes. Curr Biol. 2009;19(15):R642-R645.
40. Sasaki K, et al. Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer. Cancer Genet Cytogenet. 2007;174(1):42-47. (Pubitemid 46365984)
41. Michel LS, et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature. 2001;409(6818):355-359. (Pubitemid 32151241)
42. Lampson MA, Kapoor TM. The human mitotic checkpoint protein BubR1 regulates chromosome-spindle attachments. Nat Cell Biol. 2005;7(1):93-98. (Pubitemid 40123388)
43. Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol. 2007;8(5):379-393. (Pubitemid 46643240)
44. Manning AL, Bakhoum SF, Maffini S, Correia- Melo C, Maiato H, Compton DA. CLASP1, astrin and Kif2b form a molecular switch that regulates kinetochore-microtubule dynamics to promote mitotic progression and fidelity. EMBO J. 2010; 29(20):3531-3543.
45. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature. 2005;437(7061):1043-1047. (Pubitemid 41486987)
46. Campbell PJ, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 2011;144(1):27-40.
47. Meyerson M, Pellman D. Cancer genomes evolve by pulverizing single chromosomes. Cell. 2011;144(1):9-10.
48. Bakhoum SF, Danilova OV, Kaur P, Levy NB, Compton DA. Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma. Clin Cancer Res. 2011;17(24):7704-7711.
49. Mitelman F, Johansson B, Mertens F, eds. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. NIH Web site. http://cgap. nci.nih.gov/Chromosomes/Mitelman. Updated November 21, 2011. Accessed February 13, 2012.
50. Walther A, Houlston R, Tomlinson I. Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut. 2008;57(7):941-950. (Pubitemid 351919529)
51. Florl AR, Schulz WA. Chromosomal instability in bladder cancer. Arch Toxicol. 2008;82(3):173-182.
52. M'kacher R, et al. JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin's lymphoma patients and poor clinical outcome. Ann Oncol. 2010; 21(4):826-832.
53. Knudson CM, van de Wetering CI. Chromosomal instability and supernumerary centrosomes represent precursor defects in a mouse model of T-cell lymphoma. Cancer Res. 2007;67(17):8081-8088. (Pubitemid 47395142)
54. Kramer A, et al. Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma. Leukemia. 2003; 17(11):2207-2213. (Pubitemid 37428388)
55. Schvartzman JM, Sotillo R, Benezra R. Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer. 2010; 10(2):102-115.
56. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell. 2007; 11(1):25-36. (Pubitemid 46070223)
57. Schvartzman JM, Duijf PH, Sotillo R, Coker C, Benezra R. Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell. 2011;19(6):701-714.
58. Thompson SL, Compton DA. Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J Cell Biol. 2010;188(3):369-381.
59. Fragouli E, et al. Transcriptomic profiling of human oocytes: association of meiotic aneuploidy and altered oocyte gene expression. Mol Hum Reprod. 2010;16(8):570-582.
60. Yaspo ML, et al. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Genome Res. 2004; 14(7):1258-1267.
61. Baker DJ, Jin F, Jeganathan KB, van Deursen JM. Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell. 2009;16(6):475-486.
62. Janssen A, van der Burg M, Szuhai K, Kops GJPL, Medema RH. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science. 2011;333(6051):1895-1898.
63. Weaver BA, Cleveland DW. The aneuploidy paradox in cell growth and tumorigenesis. Cancer Cell. 2008;14(6):431-433.
64. Janssen A, Kops GJ, Medema RH. Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. Proc Natl Acad Sci U S A. 2009; 106(45):19108-19113.
65. Galimberti F, et al. Targeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastrophe. Clin Cancer Res. 2010; 16(1):109-120.
66. Rao CV, et al. Colonic tumorigenesis in BubR1(+/-) Apc(Min/+) compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proc Natl Acad Sci U S A. 2005;102(12):4365-4370. (Pubitemid 40397117)
67. Komarova NL, Wodarz D. The optimal rate of chromosome loss for the inactivation of tumor suppressor genes in cancer. Proc Natl Acad Sci U S A. 2004;101(18):7017-7021. (Pubitemid 38596435)
68. Andersson SGE, Kurland CG. Reductive evolution of resident genomes. Trends Microbiol. 1998; 6(7):263-268. (Pubitemid 28343306)
69. Weaver BA, Silk AD, Cleveland DW. Low rates of aneuploidy promote tumorigenesis while high rates of aneuploidy cause cell death and tumor suppression. Cell Oncol. 2008;30(5):453.
70. Smid M, et al. Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes. Breast Cancer Res Treat. 2011; 128(1):23-30.
71. Szallasi Z, Carter SL, Eklund AC, Kohane IS, Harris LN. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet. 2006;38(9):1043-1048. (Pubitemid 44325930)
72. Li R, et al. Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature. 2010;468(7321):321-325.
73. Guarguaglini G, Asteriti IA, Rensen WM, Lindon C, Lavia P. The Aurora-A/TPX2 complex: A novel oncogenic holoenzyme? Biochim Biophys Acta. 2010; 1806(2):230-239.
74. Birkbak NJ, et al. Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res. 2011;71(10):3447-3452.
75. Tzankov A, et al. Diffuse large B-cell lymphoma with overexpression of cyclin E substantiates poor standard treatment response and inferior outcome. Clin Cancer Res. 2006;12(7 pt 1):2125-2132.
76. Cheeseman IM, Chappie JS, Wilson-Kubalek EM, Desai A. The conserved KMN network constitutes the core microtubule-binding site of the kinetochore. Cell. 2006;127(5):983-997. (Pubitemid 44792248)
77. Cimini D, Wan XH, Hirel CB, Salmon ED. Aurora kinase promotes turnover of kinetochore microtubules to reduce chromosome segregation errors. Curr Biol. 2006;16(17):1711-1718. (Pubitemid 44691779)
78. Liu D, Vader G, Vromans MJ, Lampson MA, Lens SM. Sensing chromosome bi-orientation by spatial separation of aurora B kinase from kinetochore substrates. Science. 2009;323(5919):1350-1353.
79. Mahadevan D, Liu X, Persky DO, Miller TP, Squires MS, Wenqing Q. AT9283, a novel pan- Aurora/ JAK-2 kinase inhibitor suppresses tumor growth in aggressive B-cell non-Hodgkin's lymphoma [abstract]. Blood. 2010;116:3930.
80. Schellens JH, et al. Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors. Ann Oncol. 2011; 22(2):431-437.
81. Payton M, et al. Preclinical evaluation of AMG 900, a novel potent and highly selective panaurora kinase inhibitor with activity in taxane- resistant tumor cell lines. Cancer Res. 2010; 70(23):9846-9854.
82. Tsuboi K, et al. A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia. Leuk Res. 2011;35(10):1384-1389.
83. Roylance R, et al. Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer. Cancer Epidemiol Biomarkers Prev. 2011;20(10):2183-2194.
84. Crasta K, et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature. 2012; 482(7383):53-58.